The complexity of cancer care continues to increase, with new drugs approved and biomarkers discovered each year. Oncologists need decision support with access to up-to-date, evidence-based information to provide the best care for patients. This combined with rising healthcare costs associated with expensive cancer therapies has led to the rapid uptake in use of oncology clinical pathways, though it is cumbersome to maintain and share the pathways.
mCODE and other clinical or administrative data from the EHR provide input to mCODE enabled, computable oncology clinical pathways that are aligned with the HL7 FHIR Clinical Guidelines and mCODE implementation guides.
Standards based pathway definitions enable automated maintenance as well as sharing of definitions across institutions.
An Oncology Clinical Pathway (OCP): detailed decision tree protocol for selection of treatment options by oncologists, primarily focused on anticancer drug regimens for specific patient populations, including type, stage, and molecular subtype of disease.